NEOS THERAPEUTICS INC - COM (NEOS)

CUSIP: 64052L106

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
14,097,081
Share change
-1,203,233
Total reported value
$88,068,075
Price per share
$6.25
Number of holders
71
Value change
-$11,047,264
Number of buys
37
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 64052L106?
CUSIP 64052L106 identifies NEOS - NEOS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOS THERAPEUTICS INC - COM (NEOS) as of Q2 2018

As of 30 Jun 2018, NEOS THERAPEUTICS INC - COM (NEOS) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,097,081 shares. The largest 10 holders included FRANKLIN RESOURCES INC, BlackRock Inc., J. Goldman & Co LP, VANGUARD GROUP INC, Lyon Street Capital, LLC, Russell Investments Group, Ltd., Ghost Tree Capital, LLC, STATE STREET CORP, NEXTHERA CAPITAL LP, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 71 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.